These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 22825324

  • 1. Clinical efficacy of anti-IgE therapy for eosinophilic otitis media.
    Iino Y, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, Yoshida N.
    Otol Neurotol; 2012 Sep; 33(7):1218-24. PubMed ID: 22825324
    [Abstract] [Full Text] [Related]

  • 2. Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media.
    Iino Y, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, Yoshida N.
    Acta Otolaryngol; 2014 Apr; 134(4):366-72. PubMed ID: 24628335
    [Abstract] [Full Text] [Related]

  • 3. Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media.
    Iino Y, Usubuchi H, Kodama K, Kanazawa H, Takizawa K, Kanazawa T, Ohta Y.
    Otol Neurotol; 2010 Jan; 31(1):100-4. PubMed ID: 19816234
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Eosinophilic Otitis Media Treated with Anti-IgE Monoclonal Antibodies and A Bone Conduction Implant.
    Han YE, Kang YS, Cho Y, Park MK.
    J Int Adv Otol; 2018 Apr; 14(1):144-147. PubMed ID: 29764789
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma.
    Iino Y, Nagamine H, Kakizaki K, Komiya T, Katano H, Saruya S, Kodera K.
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):761-6. PubMed ID: 17201235
    [Abstract] [Full Text] [Related]

  • 8. Role of IgE in eosinophilic otitis media.
    Iino Y.
    Allergol Int; 2010 Sep; 59(3):233-238. PubMed ID: 20657163
    [Abstract] [Full Text] [Related]

  • 9. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
    Iino Y, Kakizaki K, Katano H, Saigusa H, Kanegasaki S.
    Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
    [Abstract] [Full Text] [Related]

  • 10. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma.
    Iino Y, Usubuchi H, Kodama K, Takizawa K, Kanazawa T, Ohta Y.
    Otol Neurotol; 2008 Oct; 29(7):949-52. PubMed ID: 18758390
    [Abstract] [Full Text] [Related]

  • 11. Risk factors associated with severity of eosinophilic otitis media.
    Kanazawa H, Yoshida N, Yamamoto H, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Iino Y.
    Auris Nasus Larynx; 2014 Dec; 41(6):513-7. PubMed ID: 25199747
    [Abstract] [Full Text] [Related]

  • 12. Reply to the comments on "Anti-IgE therapy for eosinophilic disorders".
    Iino Y.
    Otol Neurotol; 2014 Jan; 35(1):191. PubMed ID: 24270719
    [No Abstract] [Full Text] [Related]

  • 13. Comments on 'Anti-IgE therapy for eosinophilic disorders'.
    Salihoglu M, Karabacak E, Kutlu A, Haholu A.
    Otol Neurotol; 2014 Jan; 35(1):190-1. PubMed ID: 24335936
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of omalizumab in asthmatic patients with IgE levels above 700 IU/mL: a retrospective study.
    Maselli DJ, Singh H, Diaz J, Peters JI.
    Ann Allergy Asthma Immunol; 2013 Jun; 110(6):457-61. PubMed ID: 23706716
    [Abstract] [Full Text] [Related]

  • 15. Eosinophilic otitis media: a new middle ear disease entity.
    Iino Y.
    Curr Allergy Asthma Rep; 2008 Nov; 8(6):525-30. PubMed ID: 18940145
    [Abstract] [Full Text] [Related]

  • 16. Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab.
    Suzaki I, Kimura Y, Tanaka A, Hirano K, Ishibashi A, Mizuyoshi T, Ando I, Kitajima T, Watanabe S, Hinohira Y, Kobayashi H.
    Auris Nasus Larynx; 2019 Feb; 46(1):141-146. PubMed ID: 29909018
    [Abstract] [Full Text] [Related]

  • 17. New Insights into Eosinophilic Otitis Media.
    Kanazawa H, Yoshida N, Iino Y.
    Curr Allergy Asthma Rep; 2015 Dec; 15(12):76. PubMed ID: 26546407
    [Abstract] [Full Text] [Related]

  • 18. Eosinophil-derived neurotoxin, elastase, and cytokine profile in effusion from eosinophilic otitis media.
    Uchimizu H, Matsuwaki Y, Kato M, Otori N, Kojima H.
    Allergol Int; 2015 Sep; 64 Suppl():S18-23. PubMed ID: 26344075
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of Biologic Therapies for Eosinophilic Otitis Media: A Systematic Review and Meta-analysis.
    Kim DH, Hoon Park K, Jin Kang Y.
    J Int Adv Otol; 2024 Jul 29; 20(4):331-338. PubMed ID: 39161176
    [Abstract] [Full Text] [Related]

  • 20. Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma.
    Iino Y, Sekine Y, Yoshida S, Kikuchi S.
    Auris Nasus Larynx; 2021 Jun 29; 48(3):353-360. PubMed ID: 32943257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.